<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We used fluorescence in situ hybridization (FISH) assays to identify t(14;18) translocations in archival paraffin-embedded <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sections from non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) cases enrolled in a population-based study </plain></SENT>
<SENT sid="1" pm="."><plain>t(14;18) was identified in 54% of 152 cases, including 39% of diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (26 of 66 cases) and 84% of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (36 of 43 cases) </plain></SENT>
<SENT sid="2" pm="."><plain>Eighty-seven percent of t(14;18)-positive cases and 57% of t(14;18)-negative cases expressed bcl-2 </plain></SENT>
<SENT sid="3" pm="."><plain>FISH assays detected twice as many t(14;18)-positive follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> as PCR assays </plain></SENT>
<SENT sid="4" pm="."><plain>Overall, study findings support the use of FISH assays to detect t(14;18) in archival <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples for epidemiologic studies of NHL subtypes </plain></SENT>
</text></document>